Qian Xiang

Title: Qian Xiang: Innovator in Anti-Cancer Research

Introduction

Qian Xiang is a prominent inventor based in Beijing, China. He has made significant contributions to the field of pharmaceutical research, particularly in the development of compounds with anti-cancer properties. His innovative work has the potential to impact cancer treatment significantly.

Latest Patents

Qian Xiang holds a patent for an indazole hydrazide compound and its applications. This compound, represented in formula (I), features R selected from substituted alkyl, substituted alkenyl, and substituted phenyl. The substituents in the substituted alkyl and substituted alkenyl include phenyl and/or substituted phenyl, while R′ is selected from H and alkyl. Compared to prior art, this indole hydrazide compound serves as an integrin avβ3 receptor antagonist. It exhibits notable anti-prostate cancer activity and demonstrates a significant inhibitory effect on enzalutamide-resistant cell lines. Additionally, the compound shows considerable anti-tumor angiogenesis activity, making it a candidate for the preparation of anti-tumor angiogenesis drugs to inhibit tumor angiogenesis. Qian Xiang has 1 patent to his name.

Career Highlights

Qian Xiang is affiliated with Beijing Baheal Chengchuang Pharmaceutical Research and Development Co., Ltd. His work at this company focuses on advancing pharmaceutical innovations that target critical health issues, particularly cancer.

Collaborations

Qian Xiang collaborates with notable colleagues, including Yimin Cui and Xiaocong Pang. Their combined expertise enhances the research and development efforts within their organization.

Conclusion

Qian Xiang is a dedicated inventor whose work in anti-cancer research holds promise for future medical advancements. His contributions to the field are noteworthy and reflect a commitment to improving cancer treatment options.